First-of-kind implantable device to treat obesity gets FDA nod

January 18, 2015 3:12 PM

4 0

A new first of its kind appetite-suppressing implantable device to treat obesity has been approved by US FDA. The Maestro Rechargeable System has been designed to treat obesity by zapping nerves that connect the stomach and the brain.

The device makes use of the electrodes implanted in the abdomen to stimulate the vagus nerve, which sends message to the brain that the stomach is empty or full. The settings of the device can be controlled by patients and doctors using external controllers.

Read more

To category page